Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
Q1 2025 vs. Q4 2024
How the institutions holding Silence Therapeutics plc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 65 | 1 | 59 | −5 |
| Shares | 24.8M | 952.4K | 21.9M | −1.95M (−8.2%) |
| Value | $168.2M | $6.55M | $60.6M | −$101.0M (−62.5%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Silence Therapeutics plc at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nextech Invest, Ltd. | 952,400 | $2.69M | 0.62% |
| Shay Capital LLC | 47,728 | $134.6K | 0.04% |
| Jump Financial, LLC | 26,351 | $74.3K | 0.00% |
| Virtus Investment Advisers, Inc. | 24,872 | $70.1K | 0.02% |
| Jones Financial Companies LLLP | 2,500 | $8.60K | 0.00% |
| Parallel Advisors, LLC | 1,300 | $3.67K | 0.00% |
Sold out (11)
Institutions that held Silence Therapeutics plc at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Eventide Asset Management, LLC | 640,000 | $4.40M |
| Aquilo Capital Management, LLC | 367,214 | $2.53M |
| Integral Health Asset Management, LLC | 200,000 | $1.38M |
| Trexquant Investment LP | 63,663 | $438.0K |
| Verition Fund Management LLC | 24,123 | $166.0K |
| Y-Intercept (Hong Kong) Ltd | 21,217 | $146.0K |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 19,467 | $133.9K |
| Ameriprise Financial Inc | 16,360 | $112.6K |
| Custom Index Systems, LLC | 11,861 | $81.6K |
| Virtus ETF Advisers LLC | 10,772 | $74.1K |
| Wells Fargo & Company | 19 | $131 |
Not filed for Q1 2025 yet (1)
Institutions that held Silence Therapeutics plc at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nextech Invest AG | 952,400 | $6.55M |